Why the study?
Critically ill patients are at risk of drug-related problems and healthcare costs, and the clinical and economic impact of clinical pharmacists required evaluation by cost-benefit analysis in the ICU.
Does comprehensive medication management by a clinical pharmacist improve clinical and economic outcomes in neurosurgery ICU patients?
Population
162 patients in a neurosurgery ICU of a university hospital
Comparison
Comprehensive medication management by a clinical pharmacist
Design
Prospective interventional study
Follow-up
6 months
Authors
Loading...
Pharmacist interventions may cut ICU costs and DRPs; leaves open need for RCTs to confirm impact.
Does comprehensive medication management by a clinical pharmacist improve clinical and economic outcomes in neurosurgery ICU patients?
Implementation of comprehensive medication management by a clinical pharmacist in a neurosurgery ICU yields a high benefit-cost ratio and substantial net economic benefit.
Rezazadeh et al. (2021) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: